Socioeconomic position and clinical outcomes in patients with myelodysplastic syndromes: A population‐based cohort study
Open Access
- 6 September 2022
- journal article
- research article
- Published by Wiley in Hematological Oncology
- Vol. 40 (5) , 1056-1066
Abstract
Low socioeconomic position (SEP) may be associated with adverse outcomes in patients with myelodysplastic syndromes (MDS) inherent to for example, delayed diagnosis or reduced treatment intensity, but firm evidence is limited. In this study, we examined the association between SEP and clinical outcomes. We conducted a population‐based cohort study (2010–2018) of 2233 Danish patients with MDS. SEP measures included individual‐level information on education, cohabitation status and income retrieved from Statistics Denmark. Associations between SEP measures and disease severity at diagnosis were examined using binomial regression analysis. Using time‐to‐event analysis, we examined the association between SEP measures and treatment with allogeneic stem cell transplantation (allo‐HSCT), risk of progression to acute myeloid leukemia (AML), and death. Estimates were adjusted for covariates selected based on direct acyclic graphs and reported with 95% confidence intervals. Patients with a short education were more likely to be transfusion‐dependent at diagnosis (RR = 1.25, 95% CI: 1.04–1.45) and more likely to be diagnosed with higher risk MDS according to the International Prognostic Scoring System (RR = 1.29, 95% CI: 1.03–1.62), than patients with a long education. We found no clear association between SEP and risk of progression to AML. In adjusted models, the 1‐year risk of dying was higher in patients with short versus long education (RR = 1.34, 95% CI: 1.08–1.65), in patients with low versus high income (RR = 1.42, 95% CI: 1.14–1.77), and among patients who lived alone compared to those who lived with a partner (RR = 1.15, 0.98–1.35). These associations persisted after 3 years and 5 years of follow‐up. Notably, patients with a short education had a markedly lower rate of undergoing treatment with allo‐HSCT compared to patients with a long education (HR = 0.51, 95% CI: 0.31–0.84). In conclusion, low SEP and especially short education, were poor prognostic factors for adverse clinical outcomes among patients with MDS.Keywords
Funding Information
- Danish Cancer Society Research Center (R223‐A13071, R223‐A13094‐18‐S68)
- Dagmar Marshalls Fond
This publication has 30 references indexed in Scilit:
- Data quality in the Danish National Acute Leukemia Registry: a hematological data resourceClinical Epidemiology, 2013
- Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark – a nationwide studyBritish Journal of Cancer, 2012
- Danish registers on personal income and transfer paymentsScandinavian Journal of Public Health, 2011
- Danish education registersScandinavian Journal of Public Health, 2011
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 CountriesAmerican Journal of Epidemiology, 2011
- Pseudo-observations in survival analysisStatistical Methods in Medical Research, 2009
- Neighborhood socioeconomic status influences the survival of elderly patients with myelodysplastic syndromes in the United StatesCancer Causes & Control, 2009
- Socioeconomic Differences in Patient Survival Are Increasing for Acute Myeloid Leukemia and Multiple Myeloma in SwedenJournal of Clinical Oncology, 2009
- Measuring socioeconomic position in health researchBritish Medical Bulletin, 2007
- Indicators of socioeconomic position (part 1): Figure 1Journal of Epidemiology and Community Health, 2005